AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Schroder, H Agger, KE Rosthoj, S Carlsen, AT Schmiegelow, K
Citation: H. Schroder et al., Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia, DAN MED B, 48(4), 2001, pp. 275-277

Authors: Schmiegelow, K Nyvold, C Seyfarth, J Pieters, R Rottier, MMA Knabe, N Ryder, LP Madsen, HO Svejgaard, A Kaspers, GJL
Citation: K. Schmiegelow et al., Post-induction residual leukemia in childhood acute lymphoblastic leukemiaquantified by PCR correlates with in vitro prednisolone resistance, LEUKEMIA, 15(7), 2001, pp. 1066-1071

Authors: Andersen, MT Nordentoft, I Hjalgrim, LL Christiansen, CL Jakobsen, VD Hjalgrim, H Pallisgaard, N Madsen, HO Christiansen, M Ryder, LP Clausen, N Hokland, P Schmiegelow, K Melbye, M Jorgensen, P
Citation: Mt. Andersen et al., Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia, LEUKEMIA, 15(5), 2001, pp. 858-859

Authors: Schmiegelow, K Bretton-Meyer, U
Citation: K. Schmiegelow et U. Bretton-meyer, 6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia, LEUKEMIA, 15(1), 2001, pp. 74-79

Authors: Albertsen, BK Jakobsen, P Schroder, H Schmiegelow, K Carlsen, NT
Citation: Bk. Albertsen et al., Pharmacokinetics of Erwinia asparaginase after intravenous and intramuscular administration, CANC CHEMOT, 48(1), 2001, pp. 77-82

Authors: Albertsen, BK Schroder, H Jakobsen, P Muller, HJ Carlsen, NT Schmiegelow, K
Citation: Bk. Albertsen et al., Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries, BR J CL PH, 52(4), 2001, pp. 433-437

Authors: Poulsen, A Demeny, AK Plum, CB Nielsen, KG Schmiegelow, K
Citation: A. Poulsen et al., Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia, MED PED ONC, 37(1), 2001, pp. 20-23

Authors: Eldrup, E Clausen, N Scherling, B Schmiegelow, K
Citation: E. Eldrup et al., Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma, SC J CL INV, 61(6), 2001, pp. 479-490

Authors: Schmiegelow, M Lassen, S Poulsen, HS Schmiegelow, K Hertz, H Andersson, AM Skakkebaek, NE Muller, J
Citation: M. Schmiegelow et al., Gonadal status in male survivors following childhood brain tumors (vol 86,pg 2446, 2001), J CLIN END, 86(8), 2001, pp. 3967-3967

Authors: Schmiegelow, M Lassen, S Poulsen, HS Schmiegelow, K Hertz, H Andersson, AM Skakkebaek, NE Muller, J
Citation: M. Schmiegelow et al., Gonadal status in male survivors following childhood brain tumors, J CLIN END, 86(6), 2001, pp. 2446-2452

Authors: Heegaard, ED Madsen, HO Schmiegelow, K
Citation: Ed. Heegaard et al., Transient pancytopenia preceding acute lymphoblastic leukaemia (pre-ALL) precipitated by parvovirus B19, BR J HAEM, 114(4), 2001, pp. 810-813

Authors: Gustafsson, G Schmiegelow, K Forestier, E Clausen, N Glomstein, A Jonmundsson, G Mellander, L Makipernaa, A Nygaard, R Saarinen-Pihkala, UM
Citation: G. Gustafsson et al., Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation, LEUKEMIA, 14(12), 2000, pp. 2267-2275

Authors: Schmiegelow, M Lassen, S Poulsen, HS Feldt-Rasmussen, U Schmiegelow, K Hertz, H Muller, J
Citation: M. Schmiegelow et al., Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhoodbrain tumors, HORMONE RES, 54(2), 2000, pp. 53-59

Authors: Schmiegelow, M Lassen, S Poulsen, HS Feldt-Rasmussen, U Schmiegelow, K Hertz, H Muller, J
Citation: M. Schmiegelow et al., Cranial radiotherapy of childhood brain tumours: Growth hormone deficiencyand its relation to the biological effective dose of irradiation in a large population based study, CLIN ENDOCR, 53(2), 2000, pp. 191-197

Authors: Muller, O Sonksen, J Sommer, P Schmiegelow, M Petersen, PM Heilman, C Schmiegelow, K
Citation: O. Muller et al., Cryopreservation of semen from pubertal boys with cancer, MED PED ONC, 34(3), 2000, pp. 191-194

Authors: Nyvold, C Madsen, HO Ryder, LP Seyfarth, J Engel, CA Svejgaard, A Wesenberg, F Schmiegelow, K
Citation: C. Nyvold et al., Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia, J IMMUNOL M, 233(1-2), 2000, pp. 107-118

Authors: Ramakers-van Woerden, NL Pieters, R Loonen, AH Hubeek, I van Drunen, E Beverloo, HB Slater, RM Harbott, J Seyfarth, J van Wering, ER Hahlen, K Schmiegelow, K Janka-Schaub, GE Veerman, AJP
Citation: Nl. Ramakers-van Woerden et al., TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia, BLOOD, 96(3), 2000, pp. 1094-1099

Authors: Schmiegelow, M Hertz, H Schmiegelow, K Holm, K Muller, J
Citation: M. Schmiegelow et al., Insulin-like growth factor-I and insulin-like growth factor binding protein-3 during maintenance chemotherapy of acute lymphoblastic leukemia in children (vol 21, pg 268, 1999), J PED H ONC, 21(6), 1999, pp. 562-562

Authors: Schmiegelow, M Hertz, H Schmiegelow, K Holm, K Muller, J
Citation: M. Schmiegelow et al., Insulin-like growth factor-I and insulin-like growth factor binding protein-3 during maintenance chemotherapy of acute lymphoblastic leukemia in children, J PED H ONC, 21(4), 1999, pp. 268-273

Authors: Heegaard, ED Lensen, L Hornsleth, A Schmiegelow, K
Citation: Ed. Heegaard et al., The role of parvovirus B19 infection in childhood acute lymphoblastic leukemia, PED HEM ONC, 16(4), 1999, pp. 329-334

Authors: Pedersen, AMB Kok, K Petersen, G Nielsen, OH Michaelsen, KF Schmiegelow, K
Citation: Amb. Pedersen et al., Percutaneous endoscopic gastrostomy in children with cancer, ACT PAEDIAT, 88(8), 1999, pp. 849-852

Authors: Thomsen, JB Schroder, H Kristinsson, J Madsen, B Szumlanski, C Weinshilboum, R Andersen, JB Schmiegelow, K
Citation: Jb. Thomsen et al., Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells- Relation to thiopurine metabolism, CANCER, 86(6), 1999, pp. 1080-1086
Risultati: 1-22 |